1.Molecular Targeted Therapy in Modern Oncology: Imaging Assessment of Treatment Response and Toxicities.
Katherine M KRAJEWSKI ; Marta BRASCHI-AMIRFARZAN ; Pamela J DIPIRO ; Jyothi P JAGANNATHAN ; Atul B SHINAGARE
Korean Journal of Radiology 2017;18(1):28-41
Oncology is a rapidly evolving field with a shift toward personalized cancer treatment. The use of therapies targeted to the molecular features of individual tumors and the tumor microenvironment has become much more common. In this review, anti-angiogenic and other molecular targeted therapies are discussed, with a focus on typical and atypical response patterns and imaging manifestations of drug toxicities.
Drug-Related Side Effects and Adverse Reactions
;
Humans
;
Molecular Targeted Therapy*
;
Receptor, Epidermal Growth Factor
;
Response Evaluation Criteria in Solid Tumors
;
Tumor Microenvironment
;
Vascular Endothelial Growth Factor A
2.Diffuse Large B-Cell Lymphoma in the Era of Precision Oncology: How Imaging Is Helpful.
Hina J SHAH ; Abhishek R KERALIYA ; Jyothi P JAGANNATHAN ; Sree Harsha TIRUMANI ; Vikram R LELE ; Pamela J DIPIRO
Korean Journal of Radiology 2017;18(1):54-70
Diffuse large B cell lymphoma (DLBCL) is the most common histological subtype of Non-Hodgkin's lymphoma. As treatments continues to evolve, so do imaging strategies, and positron emission tomography (PET) has emerged as the most important imaging tool to guide oncologists in the diagnosis, staging, response assessment, relapse/recurrence detection,and therapeutic decision making of DLBCL. Other imaging modalities including magnetic resonance imaging (MRI), computed tomography (CT), ultrasound, and conventional radiography are also used in the evaluation of lymphoma. MRI is useful for nervous system and musculoskeletal system involvement and is emerging as a radiation free alternative to PET/CT. This article provides a comprehensive review of both the functional and morphological imaging modalities, available in the management of DLBCL.
B-Lymphocytes*
;
Decision Making
;
Diagnosis
;
Lymphoma
;
Lymphoma, B-Cell*
;
Lymphoma, Non-Hodgkin
;
Magnetic Resonance Imaging
;
Musculoskeletal System
;
Nervous System
;
Positron-Emission Tomography
;
Positron-Emission Tomography and Computed Tomography
;
Radiography
;
Ultrasonography
3.Radiology Consultation in the Era of Precision Oncology: A Review of Consultation Models and Services in the Tertiary Setting.
Pamela J DIPIRO ; Katherine M KRAJEWSKI ; Angela A GIARDINO ; Marta BRASCHI-AMIRFARZAN ; Nikhil H RAMAIYA
Korean Journal of Radiology 2017;18(1):18-27
The purpose of the article is to describe the various radiology consultation models in the Era of Precision Medicine. Since the inception of our specialty, radiologists have served as consultants to physicians of various disciplines. A variety of radiology consultation services have been described in the literature, including clinical decision support, patient-centric, subspecialty interpretation, and/or some combination of these. In oncology care in particular, case complexity often merits open dialogue with clinical providers. To explore the utility and impact of radiology consultation services in the academic setting, this article will further describe existing consultation models and the circumstances that precipitated their development. The hybrid model successful at our tertiary cancer center is discussed. In addition, the contributions of a consultant radiologist in breast cancer care are reviewed as the archetype of radiology consultation services provided to oncology practitioners.
Breast Neoplasms
;
Consultants
;
Decision Support Systems, Clinical
;
Humans
;
Precision Medicine